FdaApplication
ANDA 062692
Identifiers
- fda_app_no: ANDA062692
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 1986-06-24 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
| AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 10GM BASE/VIAL | INJECTABLE;INJECTION |
| AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
| AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE;INJECTION |
| AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE;INJECTION |
6 products